In latest AMP class actions, judge nudges parties away from beauty parade

Please login to bookmark Close

A judge overseeing competing consumer class actions against AMP over superannuation fees said he would be “reluctant” to hold a contest between the two cases, as the applicants in the rival proceedings tell the court they are in talks about possible consolidation.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Debt-laden fintech Squirrel can’t block receiver appointment

Please login to bookmark Close

A judge has refused to grant an injunction stopping the appointment of receivers to Australian cloud-based superannuation fund manager SMSF Squirrel Ltd, describing the company’s financial position as “precarious” and likely to worsen beyond its current liabilities of $7.8 million.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Country Care slams prosecutors for ‘argumentative’, ‘vague’ criminal cartel case

Please login to bookmark Close

Country Care Group has criticised the DPP for the “argumentative” tone of the notice setting out its criminal cartel case against the mobility equipment provider, and has secured an order for further clarity from prosecutors.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Ex-CBA exec facing criminal charges ordered to hand over docs in US lawsuit

Please login to bookmark Close

A former Commonwealth Bank executive facing criminal commercial bribery charges has been ordered to hand over a number of documents in a US lawsuit brought by IT company Computer Sciences Corporation, but has avoided orders compelling him to take the witness stand.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

IOOF unit’s case ‘utterly unsupportable’, Sparke Helmore tells court

Please login to bookmark Close

Sparke Helmore has refuted allegations by IOOF subsidiary Australian Executor Trustees (SA) that it failed to provide proper legal advice to the trustee on a 2012 pine plantation sale that left 4,500 investors without millions of dollars worth of assets.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Novartis wants to amend invalidated patent for MS drug

Please login to bookmark Close

Novartis has applied to amend its proposed patent for an oral form of multiple sclerosis drug Gilenya, as it appeals an invalidity ruling by IP Australia for lack of inventive step.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?